(Q37122762)

18 August 2017

title

Hormone therapy and the rise and perhaps fall of US breast cancer incidence rates: critical reflections (English)

1 reference

18 August 2017

1 reference

1

Nancy Krieger

1 reference

18 August 2017

publication date

28 March 2008

1 reference

International Journal of Epidemiology

18 August 2017

published in

1 reference

18 August 2017

volume

37

1 reference

18 August 2017

issue

3

1 reference

18 August 2017

page(s)

627-637

1 reference

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

National use of postmenopausal hormone therapy: annual trends and response to recent evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Hormone therapy prescribing patterns in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Effect of the Women's Health Initiative on osteoporosis therapy and expenditure in Medicaid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Use of postmenopausal hormone therapy since the Women's Health Initiative findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Use of menopausal hormones in the United States, 1992 through June, 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Commentary: hormone replacement therapy and coronary heart disease: four lessons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Commentary: the hormone replacement-coronary heart disease conundrum: is this the death of observational epidemiology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Commentary: observation versus intervention--what's different?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Commentary: hormones and heart disease: do trials and observational studies address different questions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Hormones and heart disease in women: the timing hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Invited commentary: hormone therapy and risk of coronary heart disease why renew the focus on the early years of menopause?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Theories for social epidemiology in the 21st century: an ecosocial perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

The decrease in breast-cancer incidence in 2003 in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Remarkable change in age-specific breast cancer incidence in the Swiss canton of Geneva and its possible relation with the use of hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Breast cancer decline mirrors fall in hormone use, spurs both debate and research

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Menopausal Estrogens and Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Postmenopausal hormone replacement therapy: scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Estrogen carcinogenesis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Risk factors for estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Breast cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Hormone replacement therapy and breast cancer risk in California.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Declines in breast cancer after the WHI: apparent impact of hormone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Hormone replacement therapy: pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: a mini-review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Racial differences in estrogen use among middle-aged and older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Prior to use of estrogen replacement therapy, are users healthier than nonusers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Trends in mammography and clinical breast examination: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Race/ethnicity and changing US socioeconomic gradients in breast cancer incidence: California and Massachusetts, 1978-2002 (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Steroids as procarcinogenic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Steroid receptors and their role in the biology and control of breast cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Trends in breast cancer by race and ethnicity: update 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Use of menopausal estrogens and medroxyprogesterone in the United States, 1982-1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Breast cancer trends. Incidence, mortality, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Cancer incidence and mortality, 1973-1995: a report card for the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Secular trends in the incidence of female breast cancer in the United States, 1973-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Breast cancer trends among black and white women in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

21 January 2018

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Cancer surveillance research: a vital subdiscipline of cancer epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Epidemiology and the web of causation: has anyone seen the spider?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

Defining and investigating social disparities in cancer: critical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYN055

21 January 2018

Identifiers

DOI

10.1093/IJE/DYN055

1 reference

18 August 2017

1 reference